$2.19
-0.03-1.35%
At Close: -
$2.20
0.010.46%
After Hours: 6:20 PM EDT
15 minutes delayed
Comments
Loading...
Immuneering (NASDAQ:IMRX) Stock Quotes, Forecast and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.
Who are Immuneering (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Connect Biopharma Hldgs (NASDAQ:CNTB) and Citius Oncology (NASDAQ:CTOR).
What is the forecast, or price target, for Immuneering (IMRX) stock?
Immuneering has a consensus price target of $17.50.
What is the current price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $2.2001 last updated October 11, 2024 at 6:20 PM EDT.
Does Immuneering (IMRX) pay a dividend?
There are no upcoming dividends for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.